New Delhi: The Delhi High Court on Thursday issued summons to Ramdev on a suit by Delhi Medical Association (DMA) seeking to restrain the yoga guru from providing false information that Patanjali’s Coronil tablet is a cure for COVID-19.
The high court bench orally asked Baba Ramdev’s counsel to tell him to respond to the suit and not make any provocative statement till the next date of hearing on July 13.
Advocate Rajiv Dutta, representing DMA, contended that many people were averse to getting vaccinated due to Baba’s false claims, which was obstructing the inoculation process and hurting lives.
Patanjali Group founder Ramdev has repeatedly courted controversy with his comments and claims, the most recent being his views on allopathic medicines, including COVID-19 vaccines.
Indian Medical Association (IMA) took exception to Ramdev’s comments that allopathy is a “stupid science” and urged the Centre to take strong action.
Also Read: IMA Files Police Complaint Against Ramdev For Insensitive Comments Against Doctors
Ramdev withdrew his comments after Union Health Minister Harsh Vardhan wrote to him. But the yoga guru has continued to make his displeasure felt on modern medicines.
On Wednesday, IMA served a defamation notice on Ramdev, demanding an unconditional apology from him within 15 days failing which the association will demand compensation of Rs 1,000 crore from him.
New Delhi: In a recent statement that has stirred political conversations, Shashi Tharoor reaffirmed his… Read More
Bhopal: Prime Minister Narendra Modi lashed out at critics of the Mahakumbh Mela at a… Read More
Balasore: With the festival of Maha Shivratri fast approaching, hectic preparations are underway at the… Read More
New Delhi: In a recent social media post, actress Kangana Ranaut sparked controversy by defending… Read More
Dubai: India restricted Pakistani to a manageable total in their Group A Champions Trophy clash,… Read More
Bhubaneswar: Hundreds of turtles being transported illegally were seized from a vehicle in Godipada area… Read More
This website uses cookies.